R1 RCM Inc Share Price OTC Bulletin Board
Equities
ACHI
US00438V1035
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- USD | - |
16/05 | Transcript : R1 RCM Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM | |
14/05 | Deutsche Bank Adjusts R1 RCM Price Target to $14 From $15, Maintains Hold Rating | MT |
Sales 2024 * | 2.61B 217B | Sales 2025 * | 2.92B 242B | Capitalization | 5.26B 437B |
---|---|---|---|---|---|
Net income 2024 * | -73M -6.06B | Net income 2025 * | 79M 6.56B | EV / Sales 2024 * | 2.75 x |
Net Debt 2024 * | 1.93B 160B | Net Debt 2025 * | 1.63B 135B | EV / Sales 2025 * | 2.36 x |
P/E ratio 2024 * |
-77.2
x | P/E ratio 2025 * |
65.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35% |
Latest transcript on R1 RCM Inc
Managers | Title | Age | Since |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22/22/22 |
Director of Finance/CFO | - | 21/22/21 | |
John Sparby
PSD | President | 48 | 01/04/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 12/19/12 |
David Dill
BRD | Director/Board Member | 55 | 18/21/18 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 01/13/01 |
1st Jan change | Capi. | |
---|---|---|
+17.74% | 83.47B | |
-29.66% | 69.72B | |
0.00% | 26.5B | |
+3.06% | 17.69B | |
-12.16% | 16.83B | |
+2.47% | 15.7B | |
+74.82% | 13.45B | |
+0.76% | 12.69B | |
+73.52% | 12.81B |
- Stock Market
- Equities
- RCM Stock
- ACHI Stock